Press Releases Latest Jul 10, 2024 Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024 Press Releases Year None202420232022202120202019201820172016201520142013 Jul 24, 2015 Theratechnologies Announces $9,600,000 Firm Offering of Units and Filing of Preliminary Short Form Prospectus Jul 14, 2015 EGRIFTA™ (Tesamorelin for Injection) Approved in Mexico Jul 14, 2015 Theratechnologies Announces Financial Results for Second Quarter of 2015 Jun 25, 2015 Theratechnologies Initiates Canadian Distribution of EGRIFTA™ (Tesamorelin for Injection) Jun 09, 2015 Tesamorelin to be Assessed in the Treatment of Liver Disease in HIV-Infected Patients May 20, 2015 Announcements in Conjunction With Theratechnologies Annual Meeting May 15, 2015 Authorization to Discontinue Class Action Proceedings Against Theratechnologies Granted Apr 17, 2015 Supreme Court of Canada rules in favour of Theratechnologies Apr 14, 2015 Theratechnologies Announces Financial Results for First Quarter of 2015 Mar 30, 2015 Health Canada Approves 1mg/vial Presentation of EGRIFTA™ (tesamorelin for injection) First page « Previous page ‹ … Page 28 Page 29 Page 30 Page 31 Current page 32 Page 33 Page 34 Page 35 Page 36 … Next page › Last page » Displaying 311 - 320 of 365
Jul 10, 2024 Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
Jul 24, 2015 Theratechnologies Announces $9,600,000 Firm Offering of Units and Filing of Preliminary Short Form Prospectus
Jun 25, 2015 Theratechnologies Initiates Canadian Distribution of EGRIFTA™ (Tesamorelin for Injection)